Brain-Controlled Lower-Limb Prosthesis Market Report 2026

Brain-Controlled Lower-Limb Prosthesis Market Overview

• Brain-Controlled Lower-Limb Prosthesis market size has reached to $0.98 billion in 2025 • Expected to grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 16.1% • Growth Driver: The Increasing Prevalence Of Diabetes-Related Amputations Driving The Growth Of The Market Due To Rising Demand For Advanced, Intuitive Mobility Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Brain-Controlled Lower-Limb Prosthesis Market?

Brain-controlled lower-limb prosthesis refers to an advanced prosthetic leg system that uses neural signals captured directly from the brain or peripheral nervous system to interpret a user’s movement intentions and translate them into precise, real-time control of the prosthetic limb. It enables more natural walking, balance, and gait adaptation by integrating brain–computer interfaces, sensors, and intelligent control algorithms to closely mimic normal human movement. The main product types of brain-controlled lower-limb prosthesis include myoelectric prosthesis, bionic prosthesis, hybrid prosthesis, and other product types. Myoelectric prosthesis refers to prosthetic limbs that are controlled by electrical signals generated by the user’s muscles to enable natural and intuitive movement. These prostheses use technologies such as electroencephalography-based systems, electromyography-based systems, electrocorticography-based systems, and other technologies. They are applied across facilities such as hospitals, rehabilitation centers, prosthetic clinics, and other applications, and are used by end users including adults, pediatrics, and elderly populations.

What Is The Brain-Controlled Lower-Limb Prosthesis Market Growth Forecast?

The brain-controlled lower-limb prosthesis market size is expected to see rapid growth in the next few years. It will grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to increasing demand for brain-controlled mobility solutions, rising integration of AI and machine learning in prosthetics, expansion of personalized prosthetic fitting technologies, growing adoption of smart rehabilitation platforms, increasing insurance coverage for advanced prosthetic systems. Major trends in the forecast period include increasing adoption of AI-controlled prosthetic gait systems, rising use of multi-modal neural signal integration, growing demand for adaptive and self-learning prosthetic limbs, expansion of sensory feedback enabled prostheses, enhanced focus on natural mobility restoration.

Global Brain-Controlled Lower-Limb Prosthesis Market Segmentation

1) By Product Type: Myoelectric Prosthesis; Bionic Prosthesis; Hybrid Prosthesis; Other Product Types 2) By Technology: Electroencephalography-Based; Electromyography-Based; Electrocorticography-Based; Other Technologies 3) By Application: Hospitals; Rehabilitation Centers; Prosthetic Clinics; Other Applications 4) By End-User: Adults; Pediatrics; Elderly Subsegments: 1) By Myoelectric Prosthesis: Surface Electrode Controlled Prosthesis; Implanted Electrode Controlled Prosthesis; Pattern Recognition Based Prosthesis; Adaptive Control Myoelectric Prosthesis; Multi Signal Input Myoelectric Prosthesis 2) By Bionic Prosthesis: Neural Interface Controlled Prosthesis; Sensory Feedback Enabled Prosthesis; Artificial Intelligence Integrated Prosthesis; Fully Integrated Bionic Limb Systems; Smart Actuator Based Bionic Prosthesis 3) By Hybrid Prosthesis: Myoelectric And Mechanical Combined Prosthesis; Neural And Myoelectric Integrated Prosthesis; Sensor Assisted Hybrid Prosthesis; Adaptive Hybrid Control Prosthesis; Multi Modal Control Hybrid Prosthesis 4) By Other Product Types: Mechanically Controlled Prosthesis; Microprocessor Assisted Prosthesis; Externally Powered Prosthesis; Custom Designed Prosthetic Systems; Experimental Prototype Prosthesis

What Are The Drivers Of The Brain-Controlled Lower-Limb Prosthesis Market?

The increasing prevalence of diabetes-related amputations is expected to propel growth of the brain-controlled lower-limb prosthesis market going forward. Diabetes-related amputations are surgical procedures to remove part of a lower limb that become necessary due to complications from long-term, poorly controlled diabetes. The increasing prevalence of diabetes-related amputations is due to poor glycemic control, which accelerates vascular damage, neuropathy, and chronic foot ulcers that often progress to severe infections and tissue loss. A brain-controlled lower-limb prosthesis helps individuals with diabetes-related amputations by restoring intuitive mobility and balance through direct neural control, enabling safer gait, reduced risk of secondary complications, and improved long-term independence. For instance, in March 2025, according to the Office for Health Improvement and Disparities, a UK-based government agency, in 2024, GP-recorded adult prevalence of type 2 diabetes in England increased to 7.0% among people aged 17 and over, up from 6.8% in March 2023. Therefore, the increasing prevalence of diabetes-related amputations is driving the growth of the brain-controlled lower-limb prosthesis industry. The increasing clinical trials are expected to propel growth of the brain-controlled lower-limb prosthesis market going forward. Clinical trials refer to carefully designed research studies conducted in human participants to evaluate the safety, efficacy, and effectiveness of new drugs, treatments, medical devices, or interventions. The increasing number of clinical trials is due to the rising prevalence of chronic and lifestyle-related diseases, which creates a greater need for developing effective treatments and therapies. Clinical trials help brain-controlled lower-limb prostheses by systematically evaluating their safety, efficacy, and real-world functionality, enabling optimized designs and evidence-based adoption for users. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, in 2023, the total number of industry clinical trials initiated in the UK rose to 426, marking an increase from 411 trials in 2022 and continuing the growth for the second consecutive year. Therefore, the increasing clinical trials are driving the growth of the brain-controlled lower-limb prosthesis industry. The growing aging population is expected to propel growth of the brain-controlled lower-limb prosthesis market going forward. An aging population refers to a demographic trend in which the proportion of older individuals in a population increases due to declining birth rates and rising life expectancy. A growing aging population is primarily due to increased life expectancy, as advances in healthcare, nutrition, and living standards enable people to live longer and survive into older age. Brain-Controlled Lower-Limb Prosthesis empowers the aging population by restoring mobility and independence through intuitive neural-driven control, enhancing their quality of life, and reducing reliance on caregivers. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the growing aging population is driving the growth of the brain-controlled lower-limb prosthesis industry.

Key Players In The Global Brain-Controlled Lower-Limb Prosthesis Market

Major companies operating in the brain-controlled lower-limb prosthesis market are Ottobock SE And Co. KGaA, Össur hf., Blatchford Limited, Fillauer Companies Inc., College Park Industries Inc., Exiii Inc., Advanced Arm Dynamics Inc., Open Bionics Ltd., BrainRobotics Inc., Blackrock Neurotech Inc., Coapt LLC, Hi-Tech Artificial Limbs Pvt. Ltd., Integrum AB, Liberating Technologies Inc., Limbitless Solutions Inc., Symbionic Inc., Unlimited Tomorrow Inc., Vincent Systems GmbH, Bionik Laboratories Corp., Credence Prosthetic Pvt. Ltd.

nan

nan

Regional Insights

North America was the largest region in the brain-controlled lower-limb prosthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Brain-Controlled Lower-Limb Prosthesis Market?

The brain-controlled lower-limb prosthesis market consists of sales of brain-controlled prosthetic legs, myoelectric lower-limb prostheses, bionic lower-limb prostheses, hybrid lower-limb prostheses, EEG-based prosthetic legs, EMG-based prosthetic legs, ECOG-based prosthetic legs, smart lower-limb prostheses, and adjustable prosthetic sockets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Brain-Controlled Lower-Limb Prosthesis Market Report 2026?

The brain-controlled lower-limb prosthesis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the brain-controlled lower-limb prosthesis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.